National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
Lung Cancer Risk Assessment and Etiology
Completed
109 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
IPF-LC-IO
Active not recruiting
200 enrolled
LUCID
Recruiting
100 enrolled
Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer.
Recruiting
180 enrolled
ALTAK
Completed
385 enrolled
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Recruiting
538 enrolled
LUSIP
Not yet recruiting
477 enrolled
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Recruiting
1,000 enrolled
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Recruiting
1,000 enrolled
Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
Rapid Autopsy and Procurement of Cancer Tissue
Recruiting
275 enrolled
A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging
Recruiting
5,500 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
COPD Care Pathway Among Patients With Cancer
Recruiting
101 enrolled
MOMENTUM
Recruiting
8,000 enrolled
The Rise in Robotic Atypical Segmentectomies
Recruiting
600 enrolled
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Recruiting
100 enrolled
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Not yet recruiting
40 enrolled
CureLung
Recruiting
500 enrolled
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
Recruiting
100 enrolled
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Withdrawn
LUNG-ROLL
Recruiting
60,000 enrolled
SPARROW
Recruiting
190 enrolled
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
Recruiting
40 enrolled
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Recruiting
700 enrolled
3D Virtual Resection for Predicting Lung Function in VATS
Not yet recruiting
60 enrolled
QVA-Mod
Not yet recruiting
180 enrolled
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Recruiting
900 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
DeniLA
Recruiting
200 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
A Registry for People With Lung Cancer
Recruiting
600 enrolled
ICARE-LCS
Not yet recruiting
7 enrolled
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
Recruiting
500 enrolled
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Recruiting
1,310 enrolled
Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
Completed
9,759 enrolled
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
Recruiting
236 enrolled
FORMOSA
Recruiting
10,000 enrolled
European Real-World Registry for Use of the Ion Endoluminal System
Recruiting
1,200 enrolled
ULSAN-ION
Recruiting
100 enrolled
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Completed
500 enrolled
CREATE
Active not recruiting
712 enrolled
PHILUCA
Enrolling by invitation
160 enrolled
Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Completed
188 enrolled
SHC2408
Recruiting
240 enrolled
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Enrolling by invitation
25 enrolled
FLAR-4DCT
Active not recruiting
202 enrolled
ALCG-01
Recruiting
400 enrolled